|
|
Vaccine Detail
|
Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine |
| Vaccine Information |
- Vaccine Name: Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: DNA vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: macrophage inflammatory protein 3 alpha (NCT01209871)
- Immunization Route: Intradermal injection (i.d.)
- Description: Patients with Asymptomatic Phase Lymphoplasmacytic Lymphoma receive autologous lymphoma immunoglobulin-derived single-chain variable fragment (scFV)-chemokine DNA vaccine intradermally. The DNA vaccine encodes macrophage inflammatory protein 3 alpha (MIP3a)-fused lymphoma idiotype in single chain format. (NCT01209871)
|
| Host Response |
|
|
| References |
NCT01209871: Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma [https://clinicaltrials.gov/study/NCT01209871]
|
|
